Pfizer and BioNTech say their COVID-19 vaccine is more than 90% effective in trials – by Michael Erman and Julie Steenhuysen (Globe and Mail – November 9, 2020)

https://www.theglobeandmail.com/

Pfizer Inc said on Monday its experimental COVID-19 vaccine was more than 90 per cent effective, a major victory in the fight against a pandemic that has killed more than a million people, battered the world’s economy and upended daily life.

Pfizer and German partner BioNTech SE are the first drugmakers to release successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they have so far found no serious safety concerns and expect to seek U.S. authorization this month for emergency use of the vaccine.

Health experts said Pfizer’s results were positive for all COVID-19 vaccines currently in development since they show the shots are going after the right target and are a proof of concept that the disease can be halted with vaccination.

“Today is a great day for science and humanity,” Albert Bourla, Pfizer’s chairman and chief executive, said.

“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”

For the rest of this article: https://www.theglobeandmail.com/business/international-business/us-business/article-a-great-day-pfizer-and-biontech-say-their-covid-19-vaccine-is-more/

No comments yet.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.